Why I’m concerned about the coronavirus: applying viral growth data metrics to a growing crisis

“We can’t predict when, but given the continual emergence of new pathogens, the increasing risk of a bioterror attack, and the ever-increasing connectedness of our world, there is a significant probability that a large and lethal modern-day pandemic will occur in our lifetime.” — Bill Gates
Coronavirus (2019-nCoV) has been grabbing headlines and generating justifiable fear and caution worldwide over the past month. The concern is well-founded. In an effort to collect my thoughts and make sense of the (often conflicting) information, I wanted to apply what I’ve read so far about 2019-nCoV to a framework that’s familiar to me.
I have spent 20 years working with viral growth data metrics as they relate to the consumer internet, and applying these concepts to the spread of 2019-nCoV has been helpful for me as I think through the best ways to protect my family. I want to stress that my area of expertise is not in virology, epidemiology, or medicine. I am sharing my thoughts more widely in case it helps anyone else make sense of the current spread of 2019-nCoV.
The most common response I get when I ask my friends if they are concerned about the 2019 novel coronavirus is: “Don’t worry about the coronavirus. You are much more likely to die of the flu.”
They are correct that the flu poses a much larger risk to myself and my family today than 2019-nCoV. According to the CDC, tens of thousands of Americans die from the flu every year. And so far, there have only been 12 diagnosed cases of 2019-nCoV in the U.S. and not a single death.
However, watching the early spread of this coronavirus that originated just over two months ago in Wuhan, China is the first time I’ve been afraid that the world could be facing a pandemic at a scale similar to the Spanish flu of 1918, which infected one third of the world’s population and killed tens of millions of people.
Why am I so concerned? It all boils down to two simple numbers: the reproduction number (R0) and the case fatality rate (CFR). For the flu, R0 is 1.3 and CFR is 0.1%. For 2019-nCoV, experts currently estimate R0 to be ~2.6 (2x the flu) and CFR to be ~1.5% (15x the flu). If we are not able to reduce these numbers quickly and drastically, 2019-nCoV could become a pandemic that infects over 1 billion people and results in over 10 million deaths.
Reproduction number (R0)
R0 (also known as the “k-factor” among growth experts) is the reproduction number of the virus. It is the average number of people who will get infected by each individual who already has the virus. For example, if R0 is 2, then 1 person will infect 2, who then infect 4, who then infect 8, etc. Viral growth is binary and extremely sensitive around an R0 of 1. If R0 > 1, growth is exponential. If R0 < 1, growth quickly abates.
It is too early to know the exact R0 of 2019-nCoV, but Professor Neil Ferguson at Imperial College London estimates it to be somewhere between 2.1 and 3.3. Even the low end of this range is extremely high. To put things in context, I once built a Facebook app called Send Hotness that had an R0 of 1.4. It grew exponentially from 1 to 5,000,000 users in 5 weeks.
R0 is driven by three main variables:
R0 = transmission risk (p) x contact rate (γ) x duration (D)
Reducing any of the three variables above (p, γ, and D) will lower R0. For example, if people wear face masks and wash their hands more frequently, that would lower the transmission risk (p). If people do not spend as much time in groups or self-quarantine at home, that would lower the contact rate (γ). And if infected people get diagnosed early and receive medical care as soon as possible, that would reduce duration (D). All of these behavioral changes will lower R0. However, the difficulty with starting at a high initial value of R0 is that you have to work extra hard to get it below the magic threshold of 1.
An additional challenge to lowering the R0 of 2019-nCoV appears to be asymptomatic transmission. According to a team of Japanese university researchers at Hokkaido University, half of secondary virus infections occur during the incubation period. What are the implications of this? Even if all secondary infections were to be prevented after the incubation period (i.e. once symptoms appear), R0 would be reduced by only 50% (i.e. from 2.6 to 1.3). If the resulting number is still above 1.0, the virus will not be contained.

